Roche's Diagnostic Foothold Gives Genentech A Leg Up In Oncology
This article was originally published in The Pink Sheet Daily
Executive Summary
Research to be presented at American Society of Clinical Oncology meeting shows role of biomarkers for lead compounds, including vemurafenib, MetMAb and Tarceva.